欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/4535/002
药品名称Gaviscon Duo sachets, suspensie voor oraal gebruik
活性成分
    • calcium carbonate 500.0 mg
    • sodium alginate 213.0 mg
剂型Oral suspension in sachet
上市许可持有人Reckitt Benckiser Healthcare B.V. Siriusdreef 14 2132 WT Hoofddorp Netherlands
参考成员国 - 产品名称Netherlands (NL)
Gaviscon Duo, suspensie voor oraal gebruik
互认成员国 - 产品名称
    • Italy (IT)
许可日期2023/07/26
最近更新日期2023/11/15
药物ATC编码
    • A02BX Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)
申请类型
  • TypeLevel1：Line Extension
  • TypeLevel2：Additional Strength/Form
  • TypeLevel3：Bibliographic Art 10 a Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Non Prescription (including OTC)
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase